Description

In this role, you will collaborate with various teams to gather and synthesize evidence for health technology assessments, ensuring compliance with EU guidelines while shaping market access strategies for oncology products. Your day-to-day responsibilities will include co-leading submissions and consultations, guiding stakeholders, and staying updated on HTA processes.

Requirements

• •Bachelor’s degree, advanced/graduate degree preferred
• •Minimum of 6 years’ experience in biopharmaceuticals industry or healthcare consulting
• •Minimum of 4 years’ experience in market access, health economics, pricing, health policy, outcomes research, or consulting
• •Strong understanding of EU payer and HTA environment
• •Advanced verbal and written communication, presentation and influencing skills
• •Ability to manage complex projects with multiple stakeholders
• •Solid knowledge of drug development processes
• •Ability to navigate ambiguity and complex trade-offs
• •Ability to frame HTA strategies and arguments
• •Hands-on experience in health technology assessment tools
• •Advanced/graduate degree (MSc, PhD, MPH, MPP, MBA)
• •Degree or diploma in health economics or economic evaluations
• •Previous experience in Oncology
• •Previous experience in an above country role
• •Direct experience leading national HTA submissions or early scientific advice
• •20% Domestic and/or International travel required
• •Prior experience in assessing evidence needs for major HTA/payer stakeholders
• •Excellent collaboration and communication skills
• •Experience in internal stakeholder management and a solution mindset
• •Strong understanding of clinical development process

Tasks

• •Collaborate with regional access leads to identify evidence needs from HTA stakeholders across Europe
• •Gather and synthesize evidence for EU HTA-related projects, including PICO surveys and data consolidation
• •Support the development of market access strategies and clinical development plans for Takeda’s oncology portfolio
• •Co-lead the preparation and submission of EU Health Technology Assessment documents, ensuring compliance with EU guidelines
• •Promote Takeda’s values and foster collaboration with cross-functional and global partners
• •Co-lead the strategy and development of high-quality HTA submission dossiers for new oncology medicines
• •Ensure timely completion of comprehensive HTA and payer evidence requirement mapping via PICO simulations
• •Represent joint EU HTA archetype’s evidence needs in internal regional and global forums
• •Co-lead Joint Scientific Consultations to gather feedback on clinical trial considerations
• •Serve as the single point of contact for all JCA and JSC related evidence topics for assigned assets
• •Guide internal stakeholders on methodological requirements for EU HTA Regulation methods and procedures
• •Maintain up-to-date knowledge of EU HTA guidelines, methods, and processes
• •Provide strategic insights on trends and collaborations of national HTA/payers and regulatory agencies